Assessment of false-negative cases of breast MR imaging in women with a familial or genetic predisposition

Breast Cancer Research and Treatment

Volumn 119, Issue 2, 2010, Pages 399-407

  Obdeijn, Inge Marie A ^a   Loo, Claudette E ^b   Rijnsburger, Adriana J ^a   Wasser, Martin N J M ^c   Bergers, Elisabeth ^d   Kok, Theo ^e   Klijn, Jan G M ^a   Boetes, Carla ^f,g  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^g MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Breast cancer; Hereditary; MRI; Screening

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; BREAST EXAMINATION; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; DIAGNOSTIC ERROR; DISEASE PREDISPOSITION; FALSE NEGATIVE RESULT; FEMALE; GENETIC PREDISPOSITION; HUMAN; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ADULT; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FALSE NEGATIVE REACTIONS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; MUTATION; NETHERLANDS; PEDIGREE; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 74849129232     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0607-7     Document Type: Article

References (35)

1. LA Kiemeney FA Lemmers RH Verhoeven KK Aben C Honing J de Nooijer PH Peeters O Visser FA Vlems 2008 The risk of cancer in the Netherlands Ned Tijdschr Geneeskd 152 41 2233 2436 1:STN:280:DC%2BD1cjktlehsg%3D%3D 19009811
2. A Antoniou PDP Pharoah S Narod HA Risch JE Eyfjord JL Hopper 2003 Average risk of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies Am J Hum Genet 72 1117 1130 1:CAS:528:DC%2BD3sXjslagtbg%3D 12677558 10.1086/375033 (Pubitemid 36530000)
3. TM Kolb J Lichy JH Newhouse 2002 Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluation Radiology 225 1 165 175 12355001 10.1148/radiol.2251011667
4. CT Brekelmans C Seynave CC Bartels MM Tilanus-Linthorst EJ Meijers-Heijboer CM Crepin AA van Geel M Menke LC Verhoog A van den Ouweland IM Obdeijn JG Klijn Rotterdam committee for medical, genetic counselling 2001 Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk J Clin Oncol 19 4 924 930 1:STN:280: DC%2BD3M3gsFamtg%3D%3D 11181654
5. M Tilanus-Linthorst L Verhoog IM Obdeijn K Bartels M Menke-Pluymers A Eggermont J Klijn H Meijers-Heijboer T van der Kwast C Brekelmans 2002 A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false-negative mammography Int J Cancer 102 91 95 1:CAS:528:DC%2BD38XnvFCru7Y%3D 12353239 10.1002/ijc.10666
6. SR Lakhani J Jacquemier JP Sloane BA Guterson TJ Anderson MJ van de Vijver LM Farid D Venter A Antoniou A Storfer E Smyth M Steel N Haites RJ Scott D Goldgar S Neuhausen PA Daly, et al. 1998 Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations J Natl Cancer Inst 90 1138 1145 1:CAS:528:DyaK1cXlsVOrs78%3D 9701363 10.1093/jnci/90.15.1138
7. IK Komenaka B-A Ditkoff K-A Joseph D Russo P Choroochurn M Ward E Horowitz MB El-Tamer FR Schnabel 2004 The development of interval breast malignancies in patients with BRCA mutations Cancer 100 2079 2083 1:CAS:528:DC%2BD2cXksF2rsr0%3D 15139048 10.1002/cncr.20221 (Pubitemid 38580324)
8. SE Harms DP Flamig KL Hesley MD Meiches RA Jensen WP Evans DA Savino RV Wells 1993 MR imaging if the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation Radiology 187 2 493 501 1:STN:280:DyaK3s3jsVOluw%3D%3D 8475297
9. SH Heywang-Kobrunner 1994 Contrast-enhanced magnetic resonance imaging of the breast Invest Radiol 29 94 104 1:STN:280:DyaK2c7ptleqtQ%3D%3D 8144345 10.1097/00004424-199405001-00018 (Pubitemid 24182863)
10. SG Orel MD Schnall 2001 MR Imaging of the breast for the detection, diagnosis, and staging of breast cancer Radiology 220 13 30 1:STN:280: DC%2BD3MzmsVOqtg%3D%3D 11425968
11. MMA Tilanus-Linthorst AIM Obdeijn CCM Bartels HJ de Koning M Oudkerk 2000 First experiences in screening women at high risk for breast cancer with MR imaging Breast Cancer Res Treat 63 53 60 1:STN:280:DC%2BD3M7hvFyruw%3D%3D 11079159 10.1023/A:1006480106487 (Pubitemid 30786991)
12. CK Kuhl RK Schmutzler CC Leutner A Kempe E Wardelmann A Hocke M Maringa U Pfeifer D Krebs HH Schild 2000 Breast imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results Radiology 215 267 279 1:STN:280:DC%2BD3c3hslajsA%3D%3D 10751498
13. E Warner DB Plewes RS Shumak GC Catzavelos LS Prospero Di MJ Yaffe V Goel E Ramsey PL Chart DCE Cole GA Taylor M Cutrara TH Samuels JP Murphy SA Narod 2001 Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer J Clin Oncol 19 3524 3531 1:STN:280:DC%2BD3MvjtlOmug%3D%3D 11481359
14. E Podo F Sardanelli R Canese D'Agnolo PG Natali M Crecco ML Grandinetti R Musumeci G Trecate S Bergonzi T De Simone B Pasisni S Manuokian GB Spatti D Vergnaghi S Morassut P Panizza A Del Maschio 2002 The Italian multi-center project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk J Exp Clin Cancer Res 21 Suppl 3 115 124 1:STN:280:DC%2BD3s%2FnsVGlsw%3D%3D 12585665
15. M Kriege CTM Brekelmans C Boetes PE Besnard HM Zonderland IM Obdeijn RA Manoliu T Kok H Peterse MMA Tilanus-linthorst SA Muller S Meijer JC Oosterwijk LVAM Beex RAEM Tollenaar HJ de Koning EJT Rutgers JGM Klijn 2004 Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition N Engl J Med 351 5 427 437 1:CAS:528:DC%2BD2cXmtFalu7o%3D 15282350 10.1056/NEJMoa031759 (Pubitemid 38988592)
16. E Warner DB Plewes KA Hill PA Causer JT Zubovits RA Jong MR Cutrara G DeBoer MJ Yaffe SJ Messner WS Meschino CA Piron SA Narod 2004 Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination JAMA 292 1317 1325 1:CAS:528:DC%2BD2cXns12rs78%3D 15367553 10.1001/jama.292.11.1317 (Pubitemid 39223222)
17. MARIBS study group 2005 Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer; a prospective multicenter cohort study (MARIBS) Lancet 365 1769 1778 10.1016/S0140-6736(05)66481-1 (Pubitemid 40744657)
18. CK Kuhl S Schrading CC Leutner N Morakkabati-Spitz E Wardelmann R Fimmers Kuhn HH Schild 2005 Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk of breast cancer J Clin Oncol 23 8469 8476 16293877 10.1200/JCO.2004.00.4960 (Pubitemid 46260243)
19. F Sardanelli F Podo G D'Agnolo A Verdecchia M Santaquilana R Musumeci G Trecate S Manoukian S Morassut C de Giacomi M Federico L Cortesi S Corcione S Cirillo V Marra 2007 Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT Study): interim results Radiology 242 698 715 17244718 10.1148/radiol.2423051965 (Pubitemid 46310082)
20. F Sardanelli F Podo 2007 Breast imaging in women at high risk of breast cancer. Is something changing in early breast cancer detection? Eur Radiol 17 873 887 17008989 10.1007/s00330-006-0389-9 (Pubitemid 46766869)
21. E Warner H Messersmith P Causer A Eisen R Shumal D Plewes 2008 Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer Ann Intern Med 148 671 679 18458280
22. Breast Imaging Reporting and Data System (BI-RADS) (2003) Ultrasound, mammography and magnetic resonance atlas. American College of Radiology, Reston, VA
23. CK Kuhl S Schrading HB Bieling E Wardelmann CC Leutner R Koenig W Kuhn HH Schild 2007 MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study Lancet 370 485 492 17693177 10.1016/S0140-6736(07)61232-X (Pubitemid 47214635)
24. AP Schouten van der Velden MS Schlooz-Vries C Boetes T Wobbes 2009 Magnetic resonance imaging of ductal carcinoma in situ: what is its clinical application? A review Am J Surg 198 2 262 269 19375068 10.1016/j.amjsurg.2009. 01.010
25. WA Berg L Guttierrez MS NessAiver WB Carter M Bhargavan RS Lewis OB Ioffe 2004 Diagnostic accuracy of mammography, clinical examination, US, and MR Imaging in preoperative assessment of breast cancer Radiology 233 830 849 15486214 10.1148/radiol.2333031484
26. JH Menell EA Morris DD Dershaw AF Abramson E Brogi L Liberman 2005 Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging Breast J 6 382 390 10.1111/j.1075-122X.2005.00121.x (Pubitemid 41743410)
27. M Facius DM Renz H Neubauer J Böttcher M Gajda O Camara WA Kaiser 2007 Characteristics of ductal carcinoma in situ in magnetic resonance imaging Clin Imaging 3 394 400 10.1016/j.clinimag.2007.04.030 (Pubitemid 350051365)
28. EL Rosen SA Smith-Foley WB DeMartini PR Eby S Peacock CD Lehman 2008 BI-RADS MRI enhancement characteristics of ductal carcinoma in situ Breast J 13 6 545 550 10.1111/j.1524-4741.2007.00513.x
29. G Vogl O Dietze C Hauser-Kronberger 2005 Angiogenic potential of ductal carcinoma in situ (DCIS) of human breast Histopathology 47 617 624 1:STN:280:DC%2BD2MnksV2htw%3D%3D 16324200 10.1111/j.1365-2559.2005.02299.x (Pubitemid 41775185)
30. AJ Guidi SJ Schnitt L Fischer K Tognazzi JR Harris HF Dvorak LF Brown 1997 Vascular permeability factor (Vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast Cancer 80 10 1945 1953 1:STN:280:DyaK1c%2FjtFKhtw%3D%3D 9366297 10.1002/(SICI)1097-0142(19971115)80:10<1945::AID-CNCR11>3.0.CO;2-Y (Pubitemid 27479789)
31. G Santamaria M Velasco B Farrus G Zanon PL Fernandez 2008 Pre-operative MRI of pure intraductal breast carcinoma: a valuable adjunct to mammography in assessing cancer extent Breast 17 186 194 17964786 10.1016/j.breast.2007.09.005
32. DR Rausch RE Hendrick 2006 How to optimize clinical breast MR Imaging practices and techniques on your 1.5-Tesla system RadioGraphics 26 1469 1484 16973776 10.1148/rg.265055176 (Pubitemid 44518775)
33. C Kuhl 2007 The current status of breast MR Imaging Radiology 244 2 356 378 17641361 10.1148/radiol.2442051620 (Pubitemid 47080868)
34. MM Tilanus-Linthorst IM Obdeijn WC Hop PA Causer MO Leach E Warner L Pointon K Hill JG Klijn RM Warren FJ Gilbert 2007 BRCA1 mutation and young age predict fast breast cancer growth in the Dutch, United Kingdom, and Canadian magnetic resonance imaging screening trials Clin Cancer Res 13 24 7357 7362 1:CAS:528:DC%2BD2sXhsVCktrzL 18094417 10.1158/1078-0432.CCR-07-0689
35. RM Warren L Pointon D Thompson R Hoff FJ Gilbert A Padhani D Easton SR Lakhani MO Leach UK Magnetic Resonance Imaging in breast screening (MARIBS) Group 2005 Reading protocol for dynamic contrast-enhanced MR images of the breast: sensitivity and specificity analysis Radiology 236 3 779 788 16118160 10.1148/radiol.2363040735 (Pubitemid 41170838)